Sophia Antipolis, France
Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, has convened an ordinary and extraordinary shareholder meeting on Tuesday May 16, 2017 at 2:00 pm CET in the offices of Drakkar – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.
The documents mentioned in articles R.225-73-1 of the French Code de commerce, including a proxy voting form, will be sent to shareholders upon written request. These documents will also be made available to shareholders at the headquarters and on the Company’s website www.nicox.com by April 25, 2017.
Shareholders may vote by proxy, by internet or by attending the shareholder meeting in person. A guide explaining how to vote, and notably how to vote by internet, will be posted on Nicox’s website by April 25, 2017. Shareholders may also contact the Company’s Investor Relations team at email@example.com for any question on the voting process.
In the event the quorum is not reached on the first call, Nicox will convene a shareholder meeting on a second call on Tuesday May 30, 2017 at 2:00 pm CET in the offices of Drakkar – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.